机构:[1]Department of Pharmacology, XuanWu Hospital of CapitalMedicalUniversity, Beijing Geriatric Medical Research Center, Key Laboratory for Neurodegenerative Diseases of Ministry of Education, 45 Changchun Street, Beijing 100053, PR China首都医科大学宣武医院[2]School of Pharmaceutical Sciences, Zhengzhou University, 100 Science Avenue, Zhengzhou, Henan Province 450001, PR China[3]Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, 12 Jichang Road, Guangzhou, Guangdong Province 510405, PR China深圳市中医院深圳医学信息中心
In the present study, we investigated the therapeutic benefit of camel iridoid glycoside (CIG), the main component extracted from Cornus officinalis, in experimental autoimmune encephalomyelitis (EAE) rats. CIG was intragastrically administered daily after EAE initiation for 20 days and reduced disease severity, incidence, disease onset and ongoing paralysis. Histopathological staining showed that CIG could reduce T cell entry to the central nervous system and microglia activation, increased brain-derived neurotrophic factor (BDNF) expression and mature oligodendrocytes, and decreased oligodendrocyte progenitor cells (OPCs). Also, CIG treatment inhibited brain JAK/STAT1/3 and reduced proinflammatory cytokines. CIG might be a novel potential therapeutic agent for multiple sclerosis (MS). (C) 2014 Elsevier B.V. All rights reserved.
基金:
National Natural Science Foundation of ChinaNational Natural Science Foundation of China [81001656, 81341088, 81273817]; Beijing Nova Star Program in Science and Technology [Z12111000250000]; Capital Medical Development Special Program [2011-1001-06]; Beijing Organization Department of Municipal Party Committee Project for Highly Talented Man [2012D005018000010]
第一作者机构:[1]Department of Pharmacology, XuanWu Hospital of CapitalMedicalUniversity, Beijing Geriatric Medical Research Center, Key Laboratory for Neurodegenerative Diseases of Ministry of Education, 45 Changchun Street, Beijing 100053, PR China
通讯作者:
推荐引用方式(GB/T 7714):
Yin Linlin,Chen Yongyan,Qu Zhao,et al.Involvement of JAK/STAT signaling in the effect of cornel iridoid glycoside on experimental autoimmune encephalomyelitis amelioration in rats[J].JOURNAL OF NEUROIMMUNOLOGY.2014,274(1-2):28-37.doi:10.1016/j.jneuroim.2014.06.022.
APA:
Yin, Linlin,Chen, Yongyan,Qu, Zhao,Zhang, Li,Wang, Qi...&Li, Lin.(2014).Involvement of JAK/STAT signaling in the effect of cornel iridoid glycoside on experimental autoimmune encephalomyelitis amelioration in rats.JOURNAL OF NEUROIMMUNOLOGY,274,(1-2)
MLA:
Yin, Linlin,et al."Involvement of JAK/STAT signaling in the effect of cornel iridoid glycoside on experimental autoimmune encephalomyelitis amelioration in rats".JOURNAL OF NEUROIMMUNOLOGY 274..1-2(2014):28-37